ARWR Shares Outstanding History
Below is a table of the ARWR shares outstanding history going back to 11/17/2011:

Date ARWR Shares Outstanding
11/17/20117.18M
12/15/201110.53M
2/1/201210.53M
5/1/201211.21M
8/3/201211.31M
12/21/201215.64M
2/8/201317.31M
5/7/201331.31M
8/5/201331.54M
12/16/201338.70M
1/31/201439.69M
5/1/201451.87M
8/11/201452.91M
11/24/201454.68M
2/5/201554.79M
5/8/201559.50M
7/31/201559.50M
12/11/201559.55M
2/5/201659.63M
5/9/201659.96M
8/8/201660.75M
12/12/201674.17M
2/3/201774.57M
5/2/201774.77M
8/1/201774.77M
12/6/201774.83M
2/7/201886.79M
5/7/201887.58M
8/6/201888.02M
12/7/201892.22M
2/6/201994.21M
5/6/201994.81M
8/2/201995.30M
11/20/201995.71M
2/3/2020101.65M
5/5/2020101.77M
7/27/2020102.29M

Also see: ARWR Market Cap History
ARWR YTD Return
ARWR Historical Shares Outstanding:
+35.72% CAGR
ARWR Historical Shares Outstanding: +35.72% CAGR

Mouse over chart for data details
11/17/2011 ...7/27/2020
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of RNA chemistries and several modes of delivery, Co.'s therapies trigger the RNA interference (RNAi) mechanism to induce knockdown of target genes. Co. is focused on developing drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved with disease. Co.'s pipeline includes, among others, ARO-AAT, a candidate for the treatment of liver disease, and ARO-APOC3, which is designed to reduce production of Apolipoprotein C-III, a component of triglyceride rich lipoproteins. We show 37 historical shares outstanding datapoints in our coverage of ARWR's shares outstanding history.

Understanding the changing numbers of ARWR shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARWR versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARWR by allowing them to research ARWR shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ARWR:
ARWR SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Arrowhead Pharmaceuticals (ARWR) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ASMB Shares Outstanding History
ASNS Shares Outstanding History
ATEC Shares Outstanding History
ATHX Shares Outstanding History
ATNX Shares Outstanding History
ATOS Shares Outstanding History
ATRA Shares Outstanding History
ATRC Shares Outstanding History
ATRI Shares Outstanding History
ATRS Shares Outstanding History
More Healthcare companies »

 

ARWR Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.